Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

Acute promyelocytic leukemia (APL) is a molecularly well-defined disease, characterized by a specific chromosomal translocation; the improvement in biologic and clinical knowledge and subsequent introduction of molecularly targeted therapies have transformed the management of APL, with survival rate...

Descripción completa

Detalles Bibliográficos
Autores principales: De Angelis, Federico, Breccia, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837932/
https://www.ncbi.nlm.nih.gov/pubmed/27182481
http://dx.doi.org/10.1007/s40487-015-0013-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837932/
https://www.ncbi.nlm.nih.gov/pubmed/27182481
http://dx.doi.org/10.1007/s40487-015-0013-8

Ejemplares similares